KEVIN ANDREW DOBBS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care THOUSAND OAKS, CA NPI 1134867369

General Payments — all program years on this page

$1,038.97

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $451.63 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $451.6322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $259.163
2023 $328.1815
2024 $451.6322

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086344547 Bayer Healthcare Pharmaceuticals Inc. $21.66 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100247580 Novo Nordisk Inc $20.05 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100637976 Novo Nordisk Inc $19.69 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104449345 AstraZeneca Pharmaceuticals LP $25.37 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105607083 AstraZeneca Pharmaceuticals LP $24.40 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107030177 ABBVIE INC. $14.08 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107030179 ABBVIE INC. $14.65 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107030181 ABBVIE INC. $14.33 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107030183 ABBVIE INC. $14.82 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107030185 ABBVIE INC. $22.53 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117542834 Amgen Inc. $28.81 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124864520 Abbott Laboratories $25.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124864522 Abbott Laboratories $17.06 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124864524 Abbott Laboratories $18.48 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124864526 Abbott Laboratories $14.52 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131505234 PFIZER INC. $17.88 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131523665 PFIZER INC. $23.46 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131551006 PFIZER INC. $24.95 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135736641 Lilly USA, LLC $29.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135771404 Lilly USA, LLC $30.93 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148031032 Bausch Health US, LLC $15.20 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150127153 SHIELD THERAPEUTICS INC $13.99 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.